Anavex®2-73 (blarcamesine) receives compassionate use authorization for pediatric patients with rett syndrome

Health canada special access program (sap) authorizes anavex®2-73 (blarcamesine) for patients after successful completion of open-label extension (ole) study

AVXL Ratings Summary

AVXL Quant Ranking